Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1,562

The novel coronavirus outbreak began in late December 2019 and rapidly spread worldwide, critically impacting public health systems. A number of already approved and marketed drugs are being tested for repurposing, including Favipiravir. We aim to investigate the efficacy and safety of Favipiravir in treatment of COVID-19 patients through a systematic review and meta-analysis. This systematic review and meta-analysis were reported in accordance with the PRISMA statement. We registered the protocol in the PROSPERO (CRD42020180032). All clinical trials which addressed the safety and efficacy of Favipiravir in comparison to other control groups for treatment of patients with confirmed infection with SARS-CoV2 were included. We searched electronic databases including LitCovid/PubMed, Scopus, Web of Sciences, Cochrane, and Scientific Information Database up to 31 December 2020.

Read more | >

Summary: A new algorithm that uses data from memory tests and blood samples is able to accurately predict an individual’s risk for developing Alzheimer’s disease.

Source: Lund University.

Researchers at Lund University in Sweden have developed an algorithm that combines data from a simple blood test and brief memory tests, to predict with great accuracy who will develop Alzheimer’s disease in the future.

Read more | >

An iPhone app that estimates biological aging discovered that life expectancy has the capacity to be almost double the current norm.

GEYLANG, Singapore — Have you made any plans for the 22nd century yet? A new study finds you might want to think about it because it’s possible for humans to live to see their 150th birthday!

Scientists in Singapore have developed an iPhone app that accurately estimates biological aging. It discovered that life expectancy has the capacity to be almost double the current norm. The findings are based on blood samples from hundreds of thousands of people in the United States and United Kingdom.

The instrument, called DOSI, uses artificial intelligence to work out body resilience, the ability to recover from injury or disease. DOSI, which stands for dynamic organism state indicator, takes into account age, illnesses, and lifestyles to make its estimates.

Read more | >

UCL researchers have created a strange robotic “third thumb” that attaches to the hand and adds a large extra digit on the opposite side of the hand from the thumb. Researchers found that using the robotic thumb can impact how the hand is represented in the brain. For the research, scientists trained people to use an extra robotic thumb and found they could effectively carry out dexterous tasks such as building a tower of blocks using a single hand with two thumbs.

Researchers said that participants trained to use the extra thumb increasingly felt like it was part of their body. Initially, the Third Thumb was part of a project seeking to reframe the way people view prosthetics from replacing a lost function to becoming an extension of the human body. UCL Professor Tamar Makin says body augmentation is a growing field aimed at extending the physical abilities of humans.

Read more | >

Four private astronauts have been strapped into a centrifuge, climbing mountains and learning how to fly a spacecraft ahead of their flight to space — the first-ever crewed space mission without any “professional astronauts” on board.

The crew is preparing to launch this upcoming September as part of the Inspiration4 mission aboard a SpaceX Crew Dragon spacecraft. The mission, privately chartered by billionaire Jared Isaacman to support St. Jude Children’s Research Hospital, recruited three crew members in addition to Isaacman for the trip which will fly around the Earth for several days. The crew includes Isaacman, St. Jude physician’s assistant and childhood bone cancer survivor Hayley Arcenaux, data engineer Chris Sembroski and geoscientist, science communicator and artist Sian Proctor.

Read more | >